2011
DOI: 10.1186/1743-422x-8-547
|View full text |Cite
|
Sign up to set email alerts
|

Sequencing and characterization of Varicella-Zoster virus vaccine strain SuduVax

Abstract: BackgroundVaricella-zoster virus (VZV) causes chickenpox in children and shingles in older people. Currently, live attenuated vaccines based on the Oka strain are available worldwide. In Korea, an attenuated VZV vaccine has been developed from a Korean isolate and has been commercially available since 1994. Despite this long history of use, the mechanism for the attenuation of the vaccine strain is still elusive. We attempted to understand the molecular basis of attenuation mechanism by full genome sequencing … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
20
0
4

Year Published

2012
2012
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 24 publications
(25 citation statements)
references
References 21 publications
1
20
0
4
Order By: Relevance
“…Hence, the right method of education with an opportunity to practice and apply what has been taught is essential. Nursing teachers should emphasize on prevention and management of Chickenpox [35][36][37].…”
Section: Nursing Educationmentioning
confidence: 99%
“…Hence, the right method of education with an opportunity to practice and apply what has been taught is essential. Nursing teachers should emphasize on prevention and management of Chickenpox [35][36][37].…”
Section: Nursing Educationmentioning
confidence: 99%
“…The above claim is bolstered by the recent publication of a third unrelated VZV sequence. In a completely independent pharmaceutical endeavor, a second live attenuated varicella vaccine called Suduvax has been produced and distributed to children in South Korea since 1994 (18). As with vOka, the South Korean vaccine product was created after serial passaging of a wild-type Korean VZV strain in cultured cells.…”
Section: Discussionmentioning
confidence: 99%
“…A varicella vaccine containing live-attenuated VZV (named Oka strain) was developed in Japan in the early 1970s 4 . Several licensed varicella vaccines are available, all using live-attenuated VZV and all based on the Oka strain except the vaccine developed in South Korea 5 . The vaccine is available as a single-antigen vaccine or in combination with measles, mumps, and rubella (MMRV).…”
Section: Introductionmentioning
confidence: 99%